Exercise blood pressure, cardiorespiratory fitness and mortality risk.


Journal

Progress in cardiovascular diseases
ISSN: 1873-1740
Titre abrégé: Prog Cardiovasc Dis
Pays: United States
ID NLM: 0376442

Informations de publication

Date de publication:
Historique:
received: 18 01 2021
accepted: 18 01 2021
pubmed: 30 1 2021
medline: 5 10 2021
entrez: 29 1 2021
Statut: ppublish

Résumé

To assess the cardiorespiratory fitness (CRF) impact on the association between exercise blood pressure (BP) and mortality risk. We assessed CRF in 15,004 US Veterans (mean age 57.5 ± 11.2 years) who completed a standardized treadmill test between January 1, 1988 and July 28, 2017 and had no evidence of ischemia. They were classified as Unfit or Fit according to the age-specific metabolic equivalents (METs) achieved <50% (6.2 ± 1.6 METs; n = 8440) or ≥ 50% (10.5 ± 2.4 METs; n = 6264). To account for the impact of resting systolic BP (SBP) on outcomes, we calculated the difference (Peak SBP-Resting SBP) and termed it SBP-Reserve. We noted a significant increase in mortality associated with SBP-Reserve ≤52 mmHg and stratified the cohort accordingly (SBP-Reserve ≤52 mmHg and > 52 mmHg). We applied multivariable Cox models to estimate hazard ratios (HR) and 95% confidence interval (CIs) for outcomes. Mortality risk was significantly elevated only in Unfit individuals with SBP-Reserve ≤52 mmHg compared to those with SBP-Reserve >52 mmHg (HR = 1.35; CI: 1.24-1.46; P < 0.001). We then assessed the CRF and SBP-Reserve interaction on mortality risk with Fit individuals with SBP-Reserve >52 mmHg serving as the referent. Mortality risk was 92% higher (HR = 1.92%; 95% CI: 1.77-2.09; P < 0.001) in Unfit individuals with SBP-Reserve ≤52 mmHg and 47% higher (HR = 1.47; 95% CI: 1.33-1.62; P < 0.001) in those with SBP-Reserve >52 mmHg. Low CRF was associated with increased mortality risk regardless of peak exercise SBP. The risk was substantially higher in individuals unable to augment their exercise SBP >52 mmHg beyond resting levels.

Identifiants

pubmed: 33513410
pii: S0033-0620(21)00012-8
doi: 10.1016/j.pcad.2021.01.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-17

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Peter Kokkinos (P)

Veterans Affairs Medical Center, Washington DC, USA; Rutgers University Department of Kinesiology and Health, New Brunswick, NJ, USA; George Washington University School of Medicine and Health Sciences, Washington DC, USA.

Charles Faselis (C)

Veterans Affairs Medical Center, Washington DC, USA; George Washington University School of Medicine and Health Sciences, Washington DC, USA.

Labros Sidossis (L)

Rutgers University Department of Kinesiology and Health, New Brunswick, NJ, USA.

Jiajia Zhang (J)

University of South Carolina, Department of Epidemiology and Biostatistics, USA.

Immanuel Babu Henry Samuel (IBH)

War Related Illness and Injury Study Center, Washington DC, USA; Henry M. Jackson Foundation for the Advancement Military Medicine, MD, USA.

Ali Ahmed (A)

Veterans Affairs Medical Center, Washington DC, USA; George Washington University School of Medicine and Health Sciences, Washington DC, USA.

Pamela Karasik (P)

Veterans Affairs Medical Center, Washington DC, USA; George Washington University School of Medicine and Health Sciences, Washington DC, USA.

Andreas Pittaras (A)

George Washington University School of Medicine and Health Sciences, Washington DC, USA.

Michael Doumas (M)

George Washington University School of Medicine and Health Sciences, Washington DC, USA.

Charalabos Grassos (C)

General Hospital of Attica Hypertension Unit, Athens, Greece.

Shirit Rosenberg (S)

VA Palo Alto Health Care System, Cardiology, Palo Alto, CA, USA.

Jonathan Myers (J)

VA Palo Alto Health Care System, Cardiology, Palo Alto, CA, USA; Stanford University, Cardiology, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH